Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Cong Xue
In Vitro and in Vivo Efficacy of Afatinib as a Single Agent or in Combination With Gemcitabine for The treatment of Nasopharyngeal Carcinoma
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Met Tyrosine Kinase Inhibitor, PF-2341066, Suppresses Growth and Invasion of Nasopharyngeal Carcinoma
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Related publications
Fasting Cycles Potentiate the Efficacy of Gemcitabine Treatment in in Vitro and in Vivo Pancreatic Cancer Models
Oncotarget
Oncology
Combination Treatment With Cetuximab in Advanced Nasopharyngeal Carcinoma Patients: A Meta-Analysis
OncoTargets and Therapy
Oncology
Pharmacology
Osthole Sensitizes With Radiotherapy to Suppress Tumorigenesis of Human Nasopharyngeal Carcinoma in Vitro and in Vivo
Cancer Management and Research
Oncology
STK405759 as a Combination Therapy With Bortezomib or Dexamethasone, in in Vitro and in Vivo Multiple Myeloma Models
Oncotarget
Oncology
A Case of Advanced Biliary Tract Cancer Successfully Treated With Single-Agent Gemcitabine Chemotherapy in Combination With Juzentaihoto
Kampo Medicine
Effects of Lentinan Alone and in Combination With Fluoropyrimidine Anticancer Agent on Growth of Human Oral Squamous Cell Carcinoma in Vitro and in Vivo
International Journal of Oncology
Cancer Research
Oncology
Commentary on “Gemcitabine: Single‐Agent and Combination Therapy in Non‐Small Cell Lung Cancer”
Oncologist
Cancer Research
Medicine
Oncology
Pemetrexed and Gemcitabine as Combination Therapy for the Treatment of Group3 Medulloblastoma
Cancer Cell
Cancer Research
Oncology
Cell Biology
Bioavailability of Triprolidine as a Single Agent or in Combination With Pseudoephedrine: A Randomized, Open‐Label Crossover Study in Healthy Volunteers
Clinical Pharmacology in Drug Development
Pharmacology
Pharmaceutical Science
